Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp increase in adjusted earnings for the fourth quarter of 2024, aided by a 7% increase in sales.
Fourth-quarter worldwide sales increased 7% year-over-year to $15.6 billion, with Pharmaceutical and Animal Health revenues growing 7% and 9% respectively.
The company reported a net profit of $3.74 billion or $1.48 per share for the December quarter, compared to a loss of $1.23 billion or $0.48 per share in the prior-year period. On an adjusted basis, earnings climbed to $1.72 per share in Q4 from $0.03 per share in the fourth quarter of 2023.
“Our business remains well-positioned thanks to the dedication of our talented global team, and I am more confident than ever in our long-term growth potential,” said Merck’s CEO Robert Davis.
Prior Performance
The post MRK Earnings: Merck Q4 2024 adj. profit jumps on strong sales growth first appeared on AlphaStreet.
Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp increase in adjusted earnings for the fourth quarter of 2024, aided by a 7% increase in sales. Fourth-quarter worldwide
The post MRK Earnings: Merck Q4 2024 adj. profit jumps on strong sales growth first appeared on AlphaStreet.
Categories AlphaGraphs, Earnings, Health Care
MRK Earnings: Merck Q4 2024 adj. profit jumps on strong sales growth
Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp increase in adjusted earnings for the fourth quarter of 2024, aided by a 7% increase in sales.
Fourth-quarter worldwide sales increased 7% year-over-year to $15.6 billion, with Pharmaceutical and Animal Health revenues growing 7% and 9% respectively.
The company reported a net profit of $3.74 billion or $1.48 per share for the December quarter, compared to a loss of $1.23 billion or $0.48 per share in the prior-year period. On an adjusted basis, earnings climbed to $1.72 per share in Q4 from $0.03 per share in the fourth quarter of 2023.
“Our business remains well-positioned thanks to the dedication of our talented global team, and I am more confident than ever in our long-term growth potential,” said Merck’s CEO Robert Davis.
Prior Performance
Listen to the conference calls as they happen. Don’t miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Infographic: How Snap (SNAP) performed in Q4 2024
Snap Inc. (NYSE: SNAP) reported revenues of $1.55 billion for the fourth quarter of 2024, up 14% year-over-year. Net income was $9 million, or $0.01 per share, compared to a
Electronic Arts (EA) Earnings: 3Q25 Key Numbers
Electronic Arts Inc. (NASDAQ: EA) reported net revenue of $1.88 billion for the third quarter of 2025, down 3% year-over-year. Net income rose 1% to $293 million and earnings per
Uber Technologies (UBER) Q4 2024 Earnings: Key financials and quarterly highlights
Uber Technologies, Inc. (NYSE: UBER) reported its fourth quarter 2024 earnings results today. Revenue grew 20% year-over-year to $12 billion, or 21% on a constant currency basis. Net income attributable
Tags